Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octane SCHEMBL27279068 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL3346967 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Methylene Chloride SCHEMBL29048529 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Methylene Chloride SCHEMBL28685517 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL8891016 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Hexadecane SCHEMBL9757807 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Decane SCHEMBL16931705 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL6588316 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL17666832 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 | |
| Heptane SCHEMBL10579117 | 1.00 | TSHR (0.73) | TSHRTHRBALDH1A1TDP1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118354842-A | Janus type spherical cellulose nano-particles | 奥克兰理工大学投资有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-117843547-A | Synthesis method of semaglutin side chain intermediate | 南京乐韬生物科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-20230399354-A1 | PREPARATION METHOD OF 2'-SUBSTITUTED PYRIMIDINE NUCLEOSIDE | BEIJING RIBIO PHARMA CO., LTD. (CN) | 2023-12-14 | — | — | US | claimed |
| CN-116836069-A | Preparation method of levosalbutamol hydrochloride | 山东锐顺药业有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-115210241-B | Solid forms of imidazopyrazine citrate | 成都倍特药业股份有限公司 | 2023-09-08 | — | — | CN | claimed |
| WO-2023138079-A1 | PREPARATION METHOD FOR 2'-SUBSTITUTED PYRIMIDINE NUCLEOSIDE | 北京瑞博奥医药科技有限公司 | 2023-07-27 | — | — | WO | claimed |
| WO-2023084383-A1 | JANUS-TYPE SPHERICAL CELLULOSE NANOPARTICLES | AUT VENTURES LIMITED (NZ) | 2023-05-19 | — | — | WO | claimed |
| CN-109956954-A | A kind of milbemycin oxime intermediate (II) preparation method of high-purity | 江苏威凌生化科技有限公司 | 2019-07-02 | — | — | CN | claimed |
| CN-108794342-A | Ammonium carboxylate salt compound, its crystal form, amorphous substance and preparation method thereof | 武汉朗来科技发展有限公司 | 2018-11-13 | — | — | CN | claimed |
| WO-2014162230-A1 | PROCESS FOR THE PURIFICATION OF NORETHINDRONE AND NORETHINDRONE ACETATE | LUPIN LIMITED (IN) | 2014-10-09 | — | — | WO | claimed |
| CN-101092441-A | Method for synthesizing nelarabine | BENCAOTIANYUAN MEDICINES ACADE (CN) | 2007-12-26 | — | — | CN | claimed |
| US-5985981-A | PRIMER FOR ROOFING USING BROMOBUTYL RUBBER, POLYURETHANES AND SOLVENTS | BRIDGESTONE/FIRESTONE, INC. (US) | 1999-11-16 | — | — | US | claimed |
| EP-0924278-A1 | An elastomeric primer for use with EPDM roofing membranes | BRIDGESTONE/FIRESTONE, INC. (US) | 1999-06-23 | — | — | EP | claimed |
| US-5174938-A | Adding crosslinking agent to polymer solution, then bonding gel particles to each other or to carrier | TOYODA GOSEI CO., LTD. (JP) | 1992-12-29 | — | — | US | claimed |
| CN-118354842-A | Janus type spherical cellulose nano-particles | 奥克兰理工大学投资有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118317677-A | Organic electroluminescent device and electronic device | 陕西莱特光电材料股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024142881-A1 | METAL COMPLEX AND ORGANIC ELECTROLUMINESCENT ELEMENT | キヤノン株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-4036845-A | Novel transient acyl derivatives of phenylbutazone | INTERX RESEARCH CORPORATION (US) | 1977-07-19 | — | — | US | disclosed |
| US-4008250-A | ANTISECRETORY, ANTIULCER | STERLING DRUG INC. (US) | 1977-02-15 | — | — | US | disclosed |
| US-3957803-A | CERTAIN TRANSIENT PRO-DRUG FORMS OF PHENYLBUTAZONE | INTERX RESEARCH CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399354-A1 | PREPARATION METHOD OF 2'-SUBSTITUTED PYRIMIDINE NUCLEOSIDE | UMPS, TYMP, DPYD | TSHR 4086/4885THRB 4250/4885ALDH1A1 2094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.